{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Asia/Jerusalem", "exchangeTimezoneShortName": "IDT", "currency": "ILA", "market": "il_market", "esgPopulated": false, "gmtOffSetMilliseconds": 10800000, "exchange": "TLV", "longName": "Rekah Pharmaceutical Industry Ltd.", "shortName": "REKAH", "regularMarketPrice": 1581.0, "regularMarketChangePercent": -2.226345, "messageBoardId": "finmb_13010819", "marketState": "CLOSED", "fiftyTwoWeekHighChangePercent": -0.26873267, "fiftyTwoWeekLow": 19.3, "fiftyTwoWeekHigh": 2162.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 1561.7, "fiftyTwoWeekLowChangePercent": 80.9171, "fiftyTwoWeekRange": "19.3 - 2162.0", "fiftyTwoWeekHighChange": -581.0, "epsTrailingTwelveMonths": -0.18, "sharesOutstanding": 11414600, "bookValue": 14.195, "fiftyDayAverage": 1601.36, "fiftyDayAverageChange": -20.359985, "fiftyDayAverageChangePercent": -0.012714184, "twoHundredDayAverage": 1717.545, "twoHundredDayAverageChange": -136.54504, "twoHundredDayAverageChangePercent": -0.079500124, "marketCap": 180464832, "priceToBook": 111.37725, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1029133800000, "priceHint": 2, "regularMarketChange": -36.0, "regularMarketTime": 1683815054, "regularMarketDayHigh": 1630.0, "regularMarketDayRange": "1568.0 - 1630.0", "regularMarketDayLow": 1568.0, "regularMarketVolume": 2666, "regularMarketPreviousClose": 1617.0, "bid": 1560.0, "ask": 1571.0, "bidSize": 300, "askSize": 69, "fullExchangeName": "Tel Aviv", "financialCurrency": "ILS", "regularMarketOpen": 1617.0, "averageDailyVolume3Month": 5174, "averageDailyVolume10Day": 3619, "symbol": "REKA.TA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "30 Hamelach Street", "city": "Holon", "zip": "5881904", "country": "Israel", "phone": "972 3 558 1233", "fax": "972 3 557 6109", "website": "https://www.rekah.co.il", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise approximately 280 drugs used in various medical fields. Rekah Pharmaceutical Industry Ltd. was founded in 1941 and is based in Holon, Israel.", "fullTimeEmployees": 399, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mordechai  Elgrabli", "age": 78, "title": "CEO & Director", "yearBorn": 1944, "fiscalYear": 2021, "totalPay": {"raw": 830000, "fmt": "830k", "longFmt": "830,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yuval  Bernshtein CPA", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2021, "totalPay": {"raw": 690000, "fmt": "690k", "longFmt": "690,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Georgette  Elgrabli", "age": 76, "title": "Director of Industrial Division & Director", "yearBorn": 1946, "fiscalYear": 2021, "totalPay": {"raw": 1327000, "fmt": "1.33M", "longFmt": "1,327,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jacob  Elgrably", "title": "Chief Exec. Officer of Ophir Shalpharm", "fiscalYear": 2021, "totalPay": {"raw": 830000, "fmt": "830k", "longFmt": "830,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Meir  Melumad", "age": 64, "title": "Director of Operations", "yearBorn": 1958, "fiscalYear": 2015, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yuval  Elgrabli", "age": 45, "title": "Deputy CEO & Director of Bus. Devel.", "yearBorn": 1977, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yaakov  Elgrabli", "title": "Chief Exec. Officer of Ophir & Shalpharm Ltd", "fiscalYear": 2018, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}